SCHEMBL7259508

SCHEMBL7259508

Clc1ccc2nc(NCc3cccs3)nc(NCc3ccc(C4=NOCCO4)cc3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 8/20 0.52
HRH1 P35367 1/20 0.52
CLK4 Q9HAZ1 6/20 0.46
DYRK1A Q13627 3/20 0.44
HTR3A P46098 2/20 0.44
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
ALOX15 P16050 2/20 0.42
MAPK1 P28482 2/20 0.42
CYP2C19 P33261 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7254578 0.82 HRH4 (0.60) HRH4HRH1CLK4HTR3ANPC1
SCHEMBL7258507 0.80 HRH4 (0.55) HRH4HRH1CLK4HTR3ANPC1
SCHEMBL7260290 0.79 HRH4 (0.54) HRH4HRH1CLK4HTR3ANPC1
SCHEMBL7255652 0.78 HRH4 (0.55) HRH4HRH1CLK4HTR3ANPC1
SCHEMBL7259297 0.73 HRH1 (0.50) HRH4HRH1
SCHEMBL7258098 0.73 HRH1 (0.47) HRH4HRH1CLK4NPC1
SCHEMBL2590769 0.73 RAD52 (0.68) HRH4HTR3AALDH1A1LMNAKMT2A
SCHEMBL7254519 0.70 NPC1 (0.52) HRH4HRH1CLK4NPC1LMNA
SCHEMBL29870144 0.69 HRH4 (1.00) HRH4HRH1HTR3A
SCHEMBL21686898 0.69 HRH4 (1.00) HRH4HRH1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed